Device Trial Radar · NCT06469398
A Post Market Device Study for the Treatment of Acne
Last checked: Nov 19, 2026Latest source record: Mar 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Actual
Start
Jul 21, 2022
Primary completion
Mar 31, 2025
Study completion Aug 18, 2025
Sponsor
- Lead sponsor
- Cutera Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 21, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 16 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
Cutera Laser SystemDevice
Subjects will receive up to 6 laser treatments
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects Who are RespondersTime frame: 12 weeks post final treatment
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Dermatology of Boca
Boca Raton, Florida
Schweiger Dermatology PC, Reseach Division
Hackensack, New Jersey
Bellaire Dermatology Associates
Bellaire, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.